Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring

Author： Muller Patrick Y   Dieterle Frank  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.9, 2009-09, pp. : 1023-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Cardiac Safety Assessment of Drugs

By Hanton Gilles  

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 213-228

Adis International

Access to resources Recommend Favorite

Biologics Safety Preclinical, Clinical and Regulatory

By Hennig Renald  

Expert Opinion on Drug Safety, Vol. 2, Iss. 6, 2003-11 ,pp. : 609-611

Informa Healthcare

Access to resources Recommend Favorite

Safety Assessment of Tretinoin Loaded Nano Emulsion and Nanostructured Lipid Carriers: A Non-invasive Trial on Human Volunteers

By  

Current Drug Delivery, Vol. 14, Iss. 4, 2017-07 ,pp. : 575-580

Bentham Science Publishers

Access to resources Recommend Favorite

Truncated Robust Distance for Clinical Laboratory Safety Data Monitoring and Assessment

By Lin Xiwu  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1174-1192

Taylor & Francis Ltd

Access to resources Recommend Favorite

Safety of Oseltamivir in Pregnancy: A Review of Preclinical and Clinical Data

By Donner Barbara  

Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. : 631-642

Adis International

Access to resources Recommend Favorite